 Persistent parvovirus infection patients human immunodeficiency virus type treatable cause anemia AIDS OBJECTIVE role parvovirus red cell aplasia patients human immunodeficiency virus type DESIGN Uncontrolled clinical trial assay serum peripheral blood cells bone marrow virus DNA hybridization immunocytochemistry techniques assays clinical findings results immunoassays antivirus antibodies immunoglobulin Ig therapy SETTING Government medical referral center university private hospitals PATIENTS patients pure red cell aplasia serologic evidence infection MEASUREMENTS MAIN RESULTS patients giant pronormoblasts bone marrow present transient aplastic crisis acute parvovirus infection High concentrations parvovirus sera several cases samples weeks months Viral DNA capsid protein present bone marrow patients active viral replication southern analysis antivirus IgG capture immunoassay low levels antivirus IgM patients symptoms fifth disease illness virus normal persons patients regimen intravenous commercial immunoglobulin cases therapy rapid reduction serum virus concentrations full recovery erythropoiesis Relapses cases DNA hybridization studies cases CONCLUSIONS parvovirus remediable cause severe chronic anemia HIV-infected patients Recognition therapy parvovirus population erythrocyte transfusion transmission virus persons immunosuppressed persons women child-bearing age